Our findings suggest that although MDR1 (ABCB1) is upregulated in some cells during inflammatory processes such as those observed in COVID-19, its expression remains cell type specific, and only a small fraction of airway epithelial cells, the main replication sites for SARS-CoV-2, exhibit detectable levels of this efflux transporter. Here, ABCB1 is linked to COVID-19.